Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Open-market sale Director sold 2,000 shares at $86.96 ($173,920)
  2. 4 Open-market sale Director sold 11,600 shares at $87.30 ($1,012,680)
  3. 4 Grant or award Director acquired 11,882 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Director sold 2,970 shares at $76.88 ($228,334)
  6. 4 Planned sale Chief Financial Officer sold 13,095 shares at an average $71.35 ($934,285)
  7. 4 Planned sale Chief Medical Officer sold 10,000 shares at $75.00 ($750,000)
  8. 4 Planned sale Chief Medical Officer sold 10,000 shares at $64.19 ($641,900)
  9. 4 Grant or award Chief Medical Officer acquired 75,000 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
  11. 4 Grant or award COO acquired 75,000 shares (grant or award)
  12. 4 Planned sale COO sold 49,493 shares at an average $63.11 ($3,123,349)
  13. 4 Planned sale Chief Medical Officer sold 40,164 shares at an average $63.11 ($2,534,661)
  14. 4 Planned sale Chief Executive Officer sold 13,187 shares at an average $66.10 ($871,703)
  15. 4 Planned sale Chief Executive Officer sold 51,726 shares at an average $69.13 ($3,575,575)
  16. 4 Planned sale Director sold 7,530 shares at $70.00 ($527,100)
  17. 4 Planned sale Director sold 8,367 shares at an average $67.65 ($566,038)
  18. 4 Planned sale Director sold 10,040 shares at an average $67.68 ($679,491)
  19. 4 Planned sale Chief Executive Officer sold 26,031 shares at an average $68.04 ($1,771,022)
  20. 4 Planned sale Director sold 10,000 shares at an average $67.66 ($676,623)

Page 1 of 25 · 497 filings